tiprankstipranks
Trending News
More News >
Shanghai Fosun Pharmaceutical (Group) Co Ltd Class H (HK:2196)
:2196

Compare Shanghai Fosun Pharmaceutical (Group) Co (2196) vs. Competitors

Compare
5 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Top Analysts' Price Target
Smart Score
Follow
Shanghai Fosun Pharmaceutical (Group) Co
HK$19.63
HK$77.65B
16.22
58.50%
3 Buy
1 Hold
0 Sell
Strong Buy
The United Laboratories International Holdings
HK$11.74
HK$23.03B
6.42
7.56%
1 Buy
0 Hold
0 Sell
Moderate Buy
Guangzhou Baiyunshan Pharmaceutical Holdings Company
HK$18.75
HK$43.70B
9.45
7.90%
Livzon Pharmaceutical Group
HK$30.94
HK$32.68B
11.53
17.93%
China Resources Pharmaceutical Group Ltd.
HK$4.61
HK$29.03B
9.55
-10.98%
1 Buy
0 Hold
0 Sell
Moderate Buy
Grand Pharmaceutical Group Limited
HK$7.80
HK$28.08B
13.32
75.90%
1 Buy
0 Hold
0 Sell
Moderate Buy

Performance Comparison

Ticker
Company Name
Price
Change
% Change
HK:2196
Shanghai Fosun Pharmaceutical (Group) Co
21.08
8.03
61.59%
HK:3933
The United Laboratories International Holdings
11.66
1.08
10.25%
HK:0874
Guangzhou Baiyunshan Pharmaceutical Holdings Company
18.71
2.19
13.27%
HK:1513
Livzon Pharmaceutical Group
29.60
5.18
21.20%
HK:3320
China Resources Pharmaceutical Group Ltd.
4.54
-0.47
-9.42%
HK:0512
Grand Pharmaceutical Group Limited
7.81
3.59
85.07%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts